Discovery of Broadly Neutralizing Antibodies (bNAbs) has given a great boost to HIV vaccine research. Study of bNAbs capable of neutralizing a broad array of different HIV strains is important for a number of reasons: (i) structures of antigens co-crystallized with bNAbs are used as templates in HIV vaccine design; (ii) bNAbs can be effective as therapeutics; (iii) preventive use of bNAbs is a promising direction in AIDS care. The goal of bNAber is to collect, analyze, compare and present bNAbs data, thus helping researchers to create HIV vaccine.

Search for anti-HIV bNAbs that fit the following criteria. All criteria are combined to create the resulting dataset.
Enter partial or complete bNAb name:
Select Ab:Select donor:Select IC50 breadth:Select IC80 breadth:Select neutralization depth:

Select Ab based on gp160 biding site:

bNAb binding sites

V2/glycans Glycans Image used with permission from Cell Host Microbe.

Citing bNAber: Eroshkin AM, LeBlanc A, Weekes D, Post K, Li Z, Rajput A, Butera ST, Burton DR, Godzik A. bNAber: database of broadly neutralizing HIV antibodies. Nucleic Acids Res. 2014 Jan 1;42(1):D1133-9.